Autoantibody subclass predominance is not driven by aberrant class switching or impaired B cell development
Clinical Immunology, vol. 257, pp. 109817
Abstract
A subset of autoimmune diseases is characterized by predominant pathogenic IgG4 autoantibodies (IgG4-AID). Why IgG4 predominates in these disorders is unknown. We hypothesized that dysregulated B cell maturation or aberrant class switching causes overrepresentation of IgG4+ B cells and plasma cells. Therefore, we compared the B cell compartment of patients from four different IgG4-AID with two IgG1-3-AID and healthy donors, using flow cytometry. Relative subset abundance at all maturation stages was normal, except for a, possibly treatment-related, reduction in immature and naïve CD5+ cells. IgG4+ B cell and plasma cell numbers were normal in IgG4-AID patients, however they had a (sub)class-independent 8-fold increase in circulating CD20-CD138+ cells. No autoreactivity was found in this subset. These results argue against aberrant B cell development and rather suggest the autoantibody subclass predominance to be antigen-driven. The similarities between IgG4-AID suggest that, despite displaying variable clinical phenotypes, they share a similar underlying immune profile.
Authors 12
-
Leiden University Medical Center
Affiliation as printed
Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands
-
Leiden University Medical Center
Affiliation as printed
Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands
-
Leiden University Medical Center
Affiliation as printed
Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands
-
Leiden University Medical Center
Affiliation as printed
Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands
-
Leiden University Medical Center
Affiliation as printed
Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands
-
Leiden University Medical Center
Affiliation as printed
Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands
-
Affiliation as printed
Department of Neurology, Erasmus University Medical Center, Rotterdam, The Netherlands
-
Affiliation as printed
Department of Neurology, Erasmus University Medical Center, Rotterdam, The Netherlands
-
Leiden University Medical Center
Affiliation as printed
Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands
-
Consejo Superior de Investigaciones Científicas · Universidad de Salamanca · Leiden University Medical Center · Centro de Investigación del Cáncer · Instituto de Biología Molecular y Celular del Cáncer de Salamanca
Affiliation as printed
Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands; Centro de Investigación del Cáncer-Instituto de Biología Molecular y Celular del Cáncer (CIC-IBMCC, USAL-CSIC-FICUS) and Department of Medicine, University of Salamanca, Salamanca, Spain
Centro de Investigación del Cáncer-Instituto de Biología Molecular y Celular del Cáncer (CIC-IBMCC, USAL-CSIC-FICUS) and Department of Medicine, University of Salamanca, Salamanca, Spain
Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands
-
Leiden University Medical Center
Affiliation as printed
Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands
-
Maartje G. M. Huijbers corresponding Aachen Department of Human Genetics Department of Neurology, Leiden University Medical Center (LUMC)
Leiden University Medical Center
Affiliation as printed
Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: m.g.m.huijbers@lumc.nl
Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands
Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands
Cited by 2 stored of 2
2 results
No patents citing this paper on Lens.org (checked 2026-10-11).